Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

ByFeliza Mirasol

November 17th 2025

3D rendered blue laboratory test tubes with red positive results | Image Credit: © mguido - stock.adobe.com

How Therapeutic and Analytical Advancements Help Drug Substance Testing Evolve

ByPatrick Lavery

November 17th 2025

Motor neuron connecting to muscle fiber, 3D illustration | Image Credit: © Julian - stock.adobe.com

Implications on SMA Care of High-Dose Nusinersen

ByFeliza Mirasol

November 17th 2025

© Michael Derrer Fuchs - stock.adobe.com

At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development

ByPatrick Lavery

November 14th 2025

PharmTech Weekly News Roundup — Week of November 10, 2025

ByPatrick Lavery

November 14th 2025

May 2003

Articles in this issue

Newsletter

Related Content

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

How Therapeutic and Analytical Advancements Help Drug Substance Testing Evolve

Implications on SMA Care of High-Dose Nusinersen

At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development

PharmTech Weekly News Roundup — Week of November 10, 2025

Trending on Pharmaceutical Technology

Implications on SMA Care of High-Dose Nusinersen

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

How Therapeutic and Analytical Advancements Help Drug Substance Testing Evolve

ADA Assays for Complex Molecule Development

Overcoming Drug Interference in an IND-Track ADA Assay